异动解读|Kodiak Sciences Inc.盘中上涨5.73%,董事大额增持后市场继续消化利好

行情直击
Oct 29

10月29日,Kodiak Sciences Inc.盘中上涨5.73%,报103.16美元/股,成交额1560.93万美元。

消息面上,市场继续消化公司董事兼重要股东Felix Baker此前大额增持的积极信号。其于9月末通过关联机构以每股80.85美元买入约1.57亿美元公司股份,被视为迄今最大一笔买入,持股进一步提升。

此外,公司此前披露两款眼科候选药物在三期试验中达到主要终点,并计划于第四季度向监管机构提交Zenkuda相关数据,强化了市场对后续申报及产品前景的预期。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10